A patient in surgery receives a neuromuscular blocking agent as an adjunct to general anesthesia. While in the postanesthesia care unit (PACU), what assessment finding is most important for the nurse to report?
a. Laryngospasm
b. Complaint of nausea
c. Weak chest wall movement
d. Patient unable to recall the correct date
ANS: C
The most serious adverse effect of the neuromuscular blocking agents is weakness of the respiratory muscles, which can lead to postoperative hypoxemia. Nausea and confusion are possible adverse effects of these drugs, but they are not as great of concern as respiratory depression. Because these medications decrease muscle contraction, laryngospasm is not a concern.
You might also like to view...
A nurse is teaching a patient with osteomalacia about the role of diet. What would be the best choice for breakfast for a patient with osteomalacia?
A) Cereal with milk, a scrambled egg, and grapefruit B) Poached eggs with sausage and toast C) Waffles with fresh strawberries and powdered sugar D) A bagel topped with butter and jam with a side dish of grapes
The nurse is caring for an obese patient who is tearful and wants diet pills to control the weight. Select the most appropriate response by the nurse
a. "Let's begin with a comprehensive diet, exercise, and behavior management pro-gram." b. "Drugs are the cornerstone of an effective weight-loss program for people who are obese rather than just overweight." c. "Drugs are indicated only for patients who have no health risks from their obesi-ty." d. "Drugs produce an excessively rapid weight loss, which could be hazardous to your heart."
Sonya drank 4 oz of juice and 8 oz of milk for breakfast, for lunch she had a 12 oz soda, then she drank
another 12 oz soda mid-afternoon. For dinner she drank 16 oz of water. The amount of fluid she drank equals __________ liters. (Use either proportion or dimensional analysis) Fill in the blank(s) with correct word
Sallie has been diagnosed with osteoporosis and is asking about the "once a month" pill to treat her condition. How do bisphosphonates treat osteoporosis?
1. By selectively activating estrogen pathways in the bone 2. By reducing bone resorption by inhibiting parathyroid hormone (PTH) 3. By reducing bone resorption and inhibiting osteoclastic activity 4. By increasing PTH production